Cargando…
Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those with...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572948/ https://www.ncbi.nlm.nih.gov/pubmed/37833884 http://dx.doi.org/10.3390/ijms241914436 |
_version_ | 1785120351804456960 |
---|---|
author | Matsuda, Shogo Oe, Katsumasa Kotani, Takuya Okazaki, Ayana Kiboshi, Takao Suzuka, Takayasu Wada, Yumiko Shiba, Hideyuki Hata, Kenichiro Shoda, Takeshi Takeuchi, Tohru |
author_facet | Matsuda, Shogo Oe, Katsumasa Kotani, Takuya Okazaki, Ayana Kiboshi, Takao Suzuka, Takayasu Wada, Yumiko Shiba, Hideyuki Hata, Kenichiro Shoda, Takeshi Takeuchi, Tohru |
author_sort | Matsuda, Shogo |
collection | PubMed |
description | This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those without ESRD to select predictive factors for ESRD. Out of 74 patients, 12 patients (16.2%) had ESRD during follow-up. Serum C4 levels were significantly higher in MPA patients who have progressed to ESRD than in those without ESRD (p = 0.009). Multivariate analyses revealed that high serum creatinine levels (odds ratio (OR) 4.4, 95% confidence interval (CI) 1.25–15.5) and high serum C4 levels (OR 1.24, 95% CI 1.03–1.49) were risk factors for ESRD. Using receiver operating characteristic analysis, the cut-off value for initial serum C4 levels and serum creatinine levels were 29.6 mg/dL and 3.54 mg/dL, respectively. Patients with MPA with a greater number of risk factors (serum C4 levels > 29.6 mg/dL and serum creatinine levels > 3.54 mg/dL) had a higher ESRD progression rate. Serum C4 levels were significantly positively correlated with serum creatinine levels and kidney Birmingham vasculitis activity score (p = 0.02 and 0.04, respectively). These results suggest that serum C4 levels are useful tools for assessing renal disease activity and prognosis in MPA. |
format | Online Article Text |
id | pubmed-10572948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105729482023-10-14 Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis Matsuda, Shogo Oe, Katsumasa Kotani, Takuya Okazaki, Ayana Kiboshi, Takao Suzuka, Takayasu Wada, Yumiko Shiba, Hideyuki Hata, Kenichiro Shoda, Takeshi Takeuchi, Tohru Int J Mol Sci Article This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those without ESRD to select predictive factors for ESRD. Out of 74 patients, 12 patients (16.2%) had ESRD during follow-up. Serum C4 levels were significantly higher in MPA patients who have progressed to ESRD than in those without ESRD (p = 0.009). Multivariate analyses revealed that high serum creatinine levels (odds ratio (OR) 4.4, 95% confidence interval (CI) 1.25–15.5) and high serum C4 levels (OR 1.24, 95% CI 1.03–1.49) were risk factors for ESRD. Using receiver operating characteristic analysis, the cut-off value for initial serum C4 levels and serum creatinine levels were 29.6 mg/dL and 3.54 mg/dL, respectively. Patients with MPA with a greater number of risk factors (serum C4 levels > 29.6 mg/dL and serum creatinine levels > 3.54 mg/dL) had a higher ESRD progression rate. Serum C4 levels were significantly positively correlated with serum creatinine levels and kidney Birmingham vasculitis activity score (p = 0.02 and 0.04, respectively). These results suggest that serum C4 levels are useful tools for assessing renal disease activity and prognosis in MPA. MDPI 2023-09-22 /pmc/articles/PMC10572948/ /pubmed/37833884 http://dx.doi.org/10.3390/ijms241914436 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Matsuda, Shogo Oe, Katsumasa Kotani, Takuya Okazaki, Ayana Kiboshi, Takao Suzuka, Takayasu Wada, Yumiko Shiba, Hideyuki Hata, Kenichiro Shoda, Takeshi Takeuchi, Tohru Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis |
title | Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis |
title_full | Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis |
title_fullStr | Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis |
title_full_unstemmed | Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis |
title_short | Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis |
title_sort | serum complement c4 levels are a useful biomarker for predicting end-stage renal disease in microscopic polyangiitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572948/ https://www.ncbi.nlm.nih.gov/pubmed/37833884 http://dx.doi.org/10.3390/ijms241914436 |
work_keys_str_mv | AT matsudashogo serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT oekatsumasa serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT kotanitakuya serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT okazakiayana serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT kiboshitakao serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT suzukatakayasu serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT wadayumiko serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT shibahideyuki serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT hatakenichiro serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT shodatakeshi serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis AT takeuchitohru serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis |